Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study

By A. Adler, I. Stratton, A. Neil, J. Yudkin, D. Matthews, C. Cull, A. Wright, R. Turner, Rury R. Holman. British medical journal, 2000

2,240 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Ophthalmology

View Paper: https://www.semanticscholar.org/paper/cdf8478f73ac3ddc0f4964f5d666b3043e4dfc62

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

Citations in the corpus

The CORE Diabetes Model: Projecting Long-term Clinical Outcomes, Costs and Costeffectiveness of Interventions in Diabetes Mellitus (Types 1 and 2) to Support Clinical and Reimbursement Decision-making (2004, methodology): “Risk adjustments for the onset of macular oedema in patients with type 1 diabetes are made for HbA 1c level and SBP. HbA 1c risk adjustment is based on DCCT data 71 and SBP adjustment is made according to data from the UKPDS 64 .”
Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes – Mechanisms, Management, and Clinical Considerations (2016, neutral): “Hypertension is another common comorbid condition in diabetes mellitus, causing left ventricular hypertrophy and contributing to the development of heart failure.(408)”
Inflammation and insulin resistance. (2003, background): “Prospective Diabetes Study (UKPDS), as mean blood pressure increased from 110 to 170 mmHg, rates of myocardial infarction increased from 18 to 35 per 1,000 person-years (31), and as mean HbA1c increased from 5 to 11%, myocardial infarction rates increased from 18 to 36 per 1,000 person-years (32).”
6. Glycemic Targets: Standards of Medical Care in Diabetes-2021. (2021, background): “Epidemiologic analyses of the DCCT (25) andUKPDS (35) demonstrate a curvilinear relationship between A1C and”
2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) (2007, background): “120 mmHg.(429) Data favouring lower blood pressure targets in patients in whom a high risk condition is due to factors other than diabetes are of variable strength.”
6. Glycemic Targets: Standards of Medical Care in Diabetes—2019 (2018, background): “However, outcome studies have clearly shown A1C to be the primary predictor of complications, and landmark trials of glycemic control such as the DCCT and UKPDS relied overwhelmingly on preprandial SMBG. Additionally, a randomized controlled trial in patients with known CVD found no CVD benefit of i”